Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CarboMedics (US) tests aldehyde-free heart valve

This article was originally published in Clinica

Executive Summary

CarboMedics (US) says PhotoFix, its non-aldehyde-fixed heart valve, has now been used at three unnamed sites in Europe. Vice-president and general manager Perry Barrs says the valve is a response to the possibility that bioprosthesis calcification may be related to the use of aldehydes in fixing and sterilisation. The trileaflet cardiac aortic valve is made from bovine pericardial tissues and fixed using a patented dye-mediated photo-oxidation process. The implant is sterilised by a non-aldehyde chemical process.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel